Recruiting Retinitis Pigmentosa Studies in Minneapolis
An Extension Study to Evaluate Safety and Efficacy in Participants Treated With CRN04894
The purpose of this study is to evaluate the long-term safety, tolerability, and efficacy of atumelnant (CRN04894)....
A Study of TAK-755 (rADAMTS13) With Little to No Plasma Exchange (PEX) Treatment in Adults With Immune-mediated Thrombotic Thrombocytopenic Purpura (iTTP)
This is a study of TAK-755 in adults with immune-mediated thrombotic thrombocytopenic purpura (iTTP). The main aim of this study is to determine the percentage of participants with a clinical (Part 1)...
About Retinitis Pigmentosa Clinical Trials in Minneapolis
Retinitis pigmentosa (RP) is a group of inherited retinal diseases that cause progressive loss of photoreceptor cells in the retina, leading to vision loss. It typically begins with night blindness and progresses to tunnel vision. Gene therapy and retinal implants are areas of active research.
There are currently 2 retinitis pigmentosa clinical trials recruiting participants in Minneapolis, MN. These studies are seeking a combined 183 participants. Research is being sponsored by Crinetics Pharmaceuticals Inc., Takeda. Clinical trial participation is free and participants receive study-related medical care at no cost.
Retinitis Pigmentosa Clinical Trials in Minneapolis — FAQ
Are there retinitis pigmentosa clinical trials in Minneapolis?
Yes, there are 2 retinitis pigmentosa clinical trials currently recruiting in Minneapolis, MN. Browse the studies on this page to find one that fits.
How do I join a clinical trial in Minneapolis?
Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Minneapolis research site will contact you about next steps.
Are clinical trials in Minneapolis free?
Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Minneapolis studies also compensate for your time and travel.
What retinitis pigmentosa treatments are being tested?
The 2 active trials in Minneapolis are testing new therapies including novel drugs, biologics, and treatment approaches for retinitis pigmentosa.
Data updated March 2, 2026 from ClinicalTrials.gov